Antipsychotics for Psychosis Secondary to Medical Conditions like Tumors
For psychosis originating from medical conditions such as tumors, atypical antipsychotics like quetiapine, olanzapine, and risperidone are recommended as first-line treatments due to their more favorable side effect profiles compared to typical antipsychotics. 1
First-Line Pharmacological Options
Atypical Antipsychotics
- Quetiapine is often preferred for psychosis secondary to medical conditions, starting at 25 mg immediate release orally, with sedating properties beneficial in agitated patients 1
- Olanzapine is recommended at a starting dose of 2.5-5 mg orally daily, but may cause drowsiness and orthostatic hypotension 1, 2
- Risperidone can be started at 0.5 mg orally (up to q12h if scheduled dosing required), with dose reduction in older patients and those with renal or hepatic impairment 2
- Aripiprazole (5 mg orally or IM) may offer benefits with fewer metabolic side effects 1, 2
Dosing Considerations
- Use lower starting doses in older or frail patients (e.g., 0.25-0.5 mg for haloperidol, 2.5 mg for olanzapine) 2
- Titrate gradually to minimize side effects while achieving symptom control 2
- For acute management, intramuscular preparations may be preferred when patients are not cooperative and require faster onset of action 3
Second-Line Options
Typical Antipsychotics
- Haloperidol can be used at 0.5-1 mg PO or SC, but carries higher risk of extrapyramidal side effects 2
- Avoid typical antipsychotics in patients with Parkinson's disease or Lewy body dementia due to risk of worsening motor symptoms 4
- Methotrimeprazine (Levomepromazine) at 5-12.5 mg PO or SC may be considered for its sedating properties 2
Special Considerations for Tumor-Related Psychosis
- Case reports demonstrate that psychosis secondary to brain tumors or other neoplasms may completely resolve after tumor removal 5, 6
- In a case of mediastinal carcinoma metastasis presenting with acute psychosis, olanzapine combined with valproic acid and perazine provided only moderate improvement until the tumor was removed 6
Monitoring and Management
Assessment
- Rule out delirium, which may present with similar symptoms to psychosis but requires different management 4
- Perform neuroimaging (MRI preferred over CT) to identify underlying tumors or other structural causes 2
- MRI without and with IV contrast may be performed if intracranial infection, tumor, inflammatory lesions, or vascular pathologies are suspected 2
Treatment Response
- Monitor for response within 30 days; refer to specialists if minimal or no improvement 1
- Document target symptoms and treatment response 2
- For pharmacological treatments used for psychosis, attempt tapering or discontinuation after 6 months of symptom stabilization if the underlying cause has been addressed 1
Side Effect Monitoring
- Document any required baseline and follow-up laboratory monitoring 2
- Monitor for extrapyramidal side effects, weight gain, QTc prolongation, and metabolic effects 2
- Adequate therapeutic trials generally require sufficient dosages over 4-6 weeks 2
Special Situations
Drug Interactions
- Consider potential drug interactions when selecting antipsychotics for patients on other medications 3
- In patients with prolactinomas requiring dopamine agonists, quetiapine has been successfully used to manage psychotic symptoms 7, 8
Family Support
- Include families in the treatment plan and provide education about the nature of the problem 4
- Provide written information supplemented with educational and psychological support for families 2
Pitfalls to Avoid
- Don't attribute psychotic symptoms solely to psychiatric illness without thorough investigation for underlying medical causes 1
- Avoid benzodiazepines as first-line treatment for agitation in delirious patients 1
- Don't use typical antipsychotics in patients with Parkinson's disease or Lewy body dementia 4